Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.91 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 04/6/15 All times are local (Market data is delayed by at least 15 minutes).

premier veterinary group plc (ARKTF) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/6/15 - $0.91
52 Week Low
04/6/15 - $0.91
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

premier veterinary group plc (ARKTF) Related Businessweek News

No Related Businessweek News Found

premier veterinary group plc (ARKTF) Details

Ark Therapeutics Group plc does not have significant operations. Prior to March 15, 2013, the company was engaged in the provision of contract development and manufacturing services to the pharmaceutical and biotech industry. Ark Therapeutics Group plc was incorporated in 2001 and is based in London, the United Kingdom.

4 Employees
Last Reported Date: 04/29/14
Founded in 2001

premier veterinary group plc (ARKTF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

premier veterinary group plc (ARKTF) Key Developments

Ark Therapeutics Group plc will Change its Name to PREMIER VETERINARY GROUP PLC

Effective March 13, 2015, Ark Therapeutics Group plc will change its name to PREMIER VETERINARY GROUP PLC.

Renamed Premier Veterinary Group Appoints Graham Dick BVSc MRCVS as Non-Executive Director

Ark Therapeutics Group plc announced that Graham Dick BVSc MRCVS has been appointed as a non-executive director with effect from March 9, 2015. Dick has extensive experience in the international Animal Health Sector having most recently been Country divisional head of the UK/Eire Animal Health Division of Bayer Healthcare.

Ark Therapeutics Group plc Announces Changes to the Management Team

As outlined in the Circular and the Prospectus the following changes to the Ark Therapeutics Group plc's Board of Directors have also taken place on February 27, 2015. Dr. David Venables and Dr. David Bloxham have resigned as Non-Executive Directors with immediate effect. Mrs. Steven has also resigned as a Non-Executive Director but will continue as Company Secretary. Dominic Tonner, Daniel Smith and Rajan Uppal have been appointed Executive Directors in the roles of Chief Executive Officer, Chief Financial Officer and Corporate Development Director respectively with immediate effect.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARKTF:US $0.91 USD 0.00

ARKTF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ARKTF.
View Industry Companies

Industry Analysis


Industry Average

Valuation ARKTF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PREMIER VETERINARY GROUP PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at